Simon Chowdhury
St Thomas' Hospital(GB)Sarah Cannon Research Institute(GB)King's College London(GB)Guy's and St Thomas' NHS Foundation Trust(GB)King's College Hospital(GB)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Cancer Genomics and Diagnostics, Radiopharmaceutical Chemistry and Applications, Cancer, Lipids, and Metabolism, PARP inhibition in cancer therapy
Most-Cited Works
- → Enzalutamide in Metastatic Prostate Cancer before Chemotherapy(2014)3,003 cited
- → Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial(2015)1,944 cited
- → Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy(2017)1,740 cited
- → Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer(2019)1,551 cited
- → Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer(2019)1,459 cited
- → Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer(2018)1,304 cited